Se-Natal One description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Se-Natal One

Seton Pharmaceuticals
Seton Pharmaceuticals

Se-Natal ONE (One Tablet Daily) Prenatal Multivitamin/Mineral Tablets


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Rx Only

SE-NATAL ONE DESCRIPTION

Se-Natal ONE is an capsule shaped, off-white coated tablet imprinted “MVC-007” on one side, and provides 12 vitamins and 5 minerals to supplement the diet during pregnancy or lactation.

Each Se-Natal ONE tablet contains:
Vitamin A (Acetate 3600 I.U. and Beta Carotene 400 I.U.) 4000 I.U.
Vitamin D3 (Cholecalciferol) 400 I.U.
Vitamin E (dI-alpha-tocopheryl acetate) 15 I.U.
Vitamin C (ascorbic acid and niacinamide ascorbate) 80 mg
Folic Acid 1 mg
Vitamin B1 (as thiamine HCl) 1.5 mg
Vitamin B2 (riboflavin) 1.6 mg
Niacinamide 17 mg
Vitamin B6 (pyridoxine HCl) 4 mg
Vitamin B12 (cyanocobalamin) 2.5 mcg
Biotin 30 mcg
Pantothenic Acid 7 mg
Calcium (calcium carbonate) 200 mg
Iron (ferrous fumarate) 60 mg
Magnesium (magnesium oxide) 100 mg
Copper (cupric oxide) 3 mg
Zinc (zinc oxide) 25 mg

Inactive Ingredients:

PVP K30, Fumed Silica, Citric Acid, TriPotassium Citrate, Microcrystalline Cellulose, Croscarmellose Sodium, Ascorbyl Palmitate, Stearic Acid, Magnesium Stearate, and Gum Arabic.

SE-NATAL ONE INDICATIONS AND USAGE

Se-Natal ONE tablets help assure an adequate intake of the vitamins and minerals listed. Folic acid helps prevent the development of megaloblastic anemia during pregnancy.

SE-NATAL ONE CONTRAINDICATIONS

Supplemental vitamins and minerals should not be prescribed for patients with hemochromatosis or Wilson’s disease.

WARNINGS

Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where Vitamin B12 is deficient.

WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

PRECAUTIONS

General:

Folic acid in doses above 1.0 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive. Pernicious anemia should be excluded before using this product since folic acid may mask the symptoms of pernicious anemia. The calcium content should be considered before prescribing for patients with kidney stones. Do not exceed the recommended dose.

Pediatric Use:

Safety and effectiveness in pediatric patients have not been established.

Geriatric Use:

Clinical studies on this product have not been performed in sufficient numbers of subjects aged 65 and over to determine whether elderly subjects respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.

SE-NATAL ONE ADVERSE REACTIONS

Adverse reactions with iron therapy may include constipation, diarrhea, nausea, vomiting, dark stools and abdominal pain. Adverse reactions with iron therapy are usually transient. Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

SE-NATAL ONE DOSAGE AND ADMINISTRATION

These tablets are partially bisected for breaking, to ease administration only. Take one tablet daily or as prescribed by a physician.

HOW SUPPLIED:

NDC 13925-103-01. Bottle of 100 tablets.

Dispense in a tight, light-resistant container with a child resistant closure.

Store at controlled room temperature 15°-30°C (59°-86°F).

Call your doctor about side effects. You may report side effects to FDA at 1-800-FDA-1088.

KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN

Rx Only

Reserved for Professional Recommendation

Manufactured For:
Seton Pharmaceuticals
Manasquan, NJ 08736
1-800-510-3401

MADE IN CANADA

Rev. NOV-2010

SETON PHARMACEUTICALS

PRINCIPAL DISPLAY PANEL:

NDC 13925-103-01

Se-Natal ONE

100 TABLETS

Rx Only

SETON PHARMACEUTICALS

Se-Natal One

Se-Natal One

Vitamin A Acetate, Cholecalciferol, .Alpha.-Tocopherol, Dl, Niacinamide Ascorbate, Folic Acid, Thiamine Hydrochloride, Riboflavin, Niacinamide, Pyridoxine Hydrochloride, Cyanocobalamin, Biotin, Pantothenic Acid, Calcium Carbonate, Ferrous Fumarate, Magnesium Oxide, Cupric Oxide and Zinc Oxide TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:13925-103
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
VITAMIN A ACETATE 4000 [iU]
CHOLECALCIFEROL CHOLECALCIFEROL 400 [iU]
.ALPHA.-TOCOPHEROL ACETATE, DL- .ALPHA.-TOCOPHEROL, DL- 15 [iU]
NIACINAMIDE ASCORBATE ASCORBIC ACID 80 mg
FOLIC ACID FOLIC ACID 1 mg
THIAMINE HYDROCHLORIDE THIAMINE 1.5 mg
RIBOFLAVIN RIBOFLAVIN 1.6 mg
NIACINAMIDE 17 mg
PYRIDOXINE HYDROCHLORIDE PYRIDOXINE 4 mg
Cyanocobalamin CYANOCOBALAMIN 2.5 ug
BIOTIN 30 ug
PANTOTHENIC ACID 7 mg
CALCIUM CARBONATE 200 mg
FERROUS FUMARATE FERROUS CATION 60 mg
magnesium oxide 100 mg
CUPRIC OXIDE CUPRIC CATION 3 mg
Zinc Oxide Zinc oxide 25 mg

Inactive Ingredients

Ingredient Name Strength
POVIDONE K30
SILICON DIOXIDE
CITRIC ACID MONOHYDRATE
Potassium Citrate Anhydrous
cellulose, microcrystalline
CROSCARMELLOSE SODIUM
ASCORBYL PALMITATE
STEARIC ACID
MAGNESIUM STEARATE
ACACIA

Product Characteristics

Color Size Imprint Code Shape
WHITE 19 mm MVC007 CAPSULE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:13925-103-01 100 in 1 BOTTLE

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
2009-04-16


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.